AUTHOREA
Log in Sign Up Browse Preprints

loading page

Laryngitis after inhalation of liposomal amikacin
  • +1
  • Atsuho Morita,
  • Ho Namkoong,
  • Makoto Hosoya,
  • Naoki Hasegawa
Atsuho Morita
Keio University School of Medicine Department of Internal Medicine

Corresponding Author:[email protected]

Author Profile
Ho Namkoong
Keio University School of Medicine Graduate School of Medicine
Author Profile
Makoto Hosoya
Keio University School of Medicine Graduate School of Medicine
Author Profile
Naoki Hasegawa
Keio University School of Medicine Graduate School of Medicine
Author Profile

Abstract

A 56-year-old female with pulmonary Mycobacterium avium complex disease started to inhale of liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after discontinuing the treatment, and no recurrence occurred even after resuming intermittent inhalation.

Peer review status:Published

07 Nov 2021Submitted to Clinical Case Reports
Show details
Hide details
09 Nov 2021Submission Checks Completed
09 Nov 2021Assigned to Editor
13 Nov 2021Reviewer(s) Assigned
21 Nov 2021Review(s) Completed, Editorial Evaluation Pending
28 Nov 2021Editorial Decision: Revise Minor
28 Dec 20211st Revision Received
28 Dec 2021Submission Checks Completed
28 Dec 2021Assigned to Editor
28 Dec 2021Review(s) Completed, Editorial Evaluation Pending
14 Jan 2022Editorial Decision: Accept
Feb 2022Published in Clinical Case Reports volume 10 issue 2. 10.1002/ccr3.5350